Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Change in Cash (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Change in Cash readings, the most recent being $2.4 million for Q1 2026.

  • On a quarterly basis, Change in Cash rose 341.75% to $2.4 million in Q1 2026 year-over-year; TTM through Jan 2026 was -$1.5 million, a 272.73% decrease, with the full-year FY2025 number at -$3.4 million, up 7.9% from a year prior.
  • Change in Cash hit $2.4 million in Q1 2026 for Pharma-Bio Serv, up from -$578540.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $7.6 million in Q4 2023 to a low of -$7.2 million in Q1 2023.
  • Median Change in Cash over the past 5 years was $223900.0 (2022), compared with a mean of -$688513.4.
  • The widest YoY moves for Change in Cash: up 3283.86% in 2023, down 586.3% in 2023.
  • Pharma-Bio Serv's Change in Cash stood at $223900.0 in 2022, then soared by 3283.86% to $7.6 million in 2023, then plummeted by 96.74% to $247174.0 in 2024, then crashed by 334.06% to -$578540.0 in 2025, then soared by 512.14% to $2.4 million in 2026.
  • The last three reported values for Change in Cash were $2.4 million (Q1 2026), -$578540.0 (Q4 2025), and $1.9 million (Q3 2025) per Business Quant data.